Elizabeth Cormier-May

Elizabeth Cormier-May has a diverse work experience in the healthcare industry. Elizabeth is currently the President & CEO and Chairman of the Board of Directors at Dragonfly Data Ventures, where they focus on empowering individuals to take control of their personal data. Additionally, they serve as the CEO of Mammogen, Inc., a company dedicated to improving breast cancer detection and treatment. Elizabeth is also a Partner & Chief Commercial Officer at IV BioHoldings, working towards advancing precision health solutions. Elizabeth has served on the board of directors at Safe & Green Holdings Corp. and as an Advisory Board Member at 2San, PragmaDx, Inc., and Boat School Ventures. Previously, they held leadership positions at Exosome Diagnostics, Definiens, and HTG Molecular Diagnostics, focusing on commercial diagnostics and business development in the pharmaceutical and molecular diagnostics sectors. Overall, Elizabeth has a strong background in healthcare innovation, diagnostics, and commercialization.

Elizabeth Cormier-May attended Wheaton College Massachusetts from 2000 to 2004, where they obtained a Bachelor of Science degree with ACS Certification in Organic Chemistry. It is unclear when they started or ended their education at Northeastern University, but they pursued studies in Chemistry and Chemical Biology during their time there.